These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33422676)

  • 41. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
    Bruntraeger M; Byrne M; Long K; Bassett AR
    Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a pVEC peptide-based ribonucleoprotein (RNP) delivery system for genome editing using CRISPR/Cas9 in Chlamydomonas reinhardtii.
    Kang S; Jeon S; Kim S; Chang YK; Kim YC
    Sci Rep; 2020 Dec; 10(1):22158. PubMed ID: 33335164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-viral
    Byambaa S; Uosaki H; Ohmori T; Hara H; Endo H; Nureki O; Hanazono Y
    Mol Ther Methods Clin Dev; 2021 Mar; 20():451-462. PubMed ID: 33614821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
    Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
    Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells.
    Yen J; Fiorino M; Liu Y; Paula S; Clarkson S; Quinn L; Tschantz WR; Klock H; Guo N; Russ C; Yu VWC; Mickanin C; Stevenson SC; Lee C; Yang Y
    Sci Rep; 2018 Nov; 8(1):16304. PubMed ID: 30389991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient genome editing in Fusarium oxysporum based on CRISPR/Cas9 ribonucleoprotein complexes.
    Wang Q; Cobine PA; Coleman JJ
    Fungal Genet Biol; 2018 Aug; 117():21-29. PubMed ID: 29763675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models.
    Sano S; Wang Y; Evans MA; Yura Y; Sano M; Ogawa H; Horitani K; Doviak H; Walsh K
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31633690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene Editing in Green Alga Chlamydomonas reinhardtii via CRISPR-Cas9 Ribonucleoproteins.
    Kelterborn S; Boehning F; Sizova I; Baidukova O; Evers H; Hegemann P
    Methods Mol Biol; 2022; 2379():45-65. PubMed ID: 35188655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microfluidic-assisted biomineralization of CRISPR/Cas9 in near-infrared responsive metal-organic frameworks for programmable gene-editing.
    Xu X; Liu C; Wang S; Mäkilä E; Wang J; Koivisto O; Zhou J; Rosenholm JM; Shu Y; Zhang H
    Nanoscale; 2022 Nov; 14(42):15832-15844. PubMed ID: 36255392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
    Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
    PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones.
    Smith RH; Chen YC; Seifuddin F; Hupalo D; Alba C; Reger R; Tian X; Araki D; Dalgard CL; Childs RW; Pirooznia M; Larochelle A
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33322084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral Microto-Nano Genome-Editing System Enabling Targeted Delivery and Conditional Activation of CRISPR-Cas9 for Gene Therapy of Inflammatory Bowel Disease.
    Lin S; Han S; Wang X; Wang X; Shi X; He Z; Sun M; Sun J
    ACS Nano; 2024 Sep; 18(37):25657-25670. PubMed ID: 39215751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonviral Ex Vivo Genome Editing in Mouse Bona Fide Hematopoietic Stem Cells with CRISPR/Cas9.
    Hara H; Munkh-Erdene N; Byambaa S; Hanazono Y
    Methods Mol Biol; 2023; 2637():213-221. PubMed ID: 36773149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient Editing of the CXCR4 Locus Using Cas9 Ribonucleoprotein Complexes Stabilized with Polyglutamic Acid.
    Golubev DS; Komkov DS; Shepelev MV; Mazurov DV; Kruglova NA
    Dokl Biol Sci; 2023 Dec; 513(Suppl 1):S28-S32. PubMed ID: 38190037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D; Ramadan L; Kruglova N
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A carrier-free multiplexed gene editing system applicable for suspension cells.
    Ju A; Lee SW; Lee YE; Han KC; Kim JC; Shin SC; Park HJ; EunKyeong Kim E; Hong S; Jang M
    Biomaterials; 2019 Oct; 217():119298. PubMed ID: 31280073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Genome Editing System for Therapeutical Targeting of Stem Cells.
    Frati G; Miccio A
    Methods Mol Biol; 2021; 2185():383-398. PubMed ID: 33165862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
    Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A
    Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.